Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo

Molecular Cancer Therapeutics

Volumn 1, Issue 2, 2001, Pages 133-139

  Ciccolini, Joseph ^a   Cuq, Pierre ^b   Evrard, Alexandre ^b   Giacometti, Sarah ^a   Pelegrin, André ^c   Aubert, Claude ^a   Cano, Jean Paul ^b   Iliadis, Athanassios ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIV MONTPELLIER   (France)

^c CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYINOSINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUOROURACIL; INOSINE; PYRIMIDINE NUCLEOTIDE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; TRITIUM;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; COLORECTAL TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL DIVISION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DRUG SYNERGISM; FLUOROURACIL; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INOSINE; MICE; MICE, NUDE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; THYMINE NUCLEOTIDES; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0035554258     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kent, R. J., and Heidelberger, C. Fluorinated pyrimidines. XL. The reduction of 5-fluorouridine 5′-diphosphate by ribonucleotide reductase. Mol. Pharmacol., 8: 465-475, 1972.
2. Peters, G. J., Laurensse, E., Leyva, A., Lankelma, J., and Pinedo, H. M. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res., 46: 20-28, 1986. (Pubitemid 16189022)
3. Peters, G. J., Van Groeningen, C. J., Laurensse, E. J., and Pinedo, H. M. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa. Cancer (Phila.), 68: 1903-1309, 1991.
4. Heidelberger, C., Danenberg, P. V., and Moran, R. G. Fluorinated pyrimidines and their nucleosides. Adv. Enzymol. Relat. Areas Mol. Biol., 54: 58-119, 1983.
5. Kufe, D. W., and Major, P. P. 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. J. Biol. Chem., 256: 9802-9805, 1981. (Pubitemid 12176177)
6. Geoffroy, F. J., Allegra, C. J., Sinha, B., and Grem, J. L. Enhanced cytotoxicity with interleukin-1α and 5-fluorouracil in HCT116 colon cancer cells. Oncol. Res., 6: 581-591, 1994.
7. Pritchard, D. M., Watson, A. J., Potten, C. S., Jackman, A. L., and Hickman, J. A. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc. Natl. Acad. Sci. USA, 94: 1795-1799, 1997. (Pubitemid 27113915)
8. Schwartz, E. L., Baptiste, N., O'Connor, C. J., Wadler, S., and Otter, B. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase. Cancer Res., 54: 1472-1478, 1994.
9. Schwartz, E. L., Baptiste, N., Wadler, S., and Makower, D. Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J. Biol. Chem., 270: 19073-19077, 1995.
10. Patterson, A. V., Zhang, H., Maghaddam, A., Bicknell, T., Talbot, D. C., Straford, I. J., and Harris, A. L. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-desoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br. J. Cancer, 72: 669-675, 1995.
11. Evans, R. M., Laskin, J. D., and Hakala, M. T. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res., 41: 3288-3295, 1981. (Pubitemid 11063590)
12. Schwartz, E. L., Baptiste, N., Megati, S., Wadler, S., and Otter, B. A. 5-Ethoxy-2′-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression. Cancer Res., 55: 3543-3550, 1995.
13. Ciccolini, J., Peillard, L., Aubert, C., Formento, P., Milano, G., and Catalin, J. Monitoring of intracellular activation of FUra to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study. Fundam. Clin. Pharmacol., 14: 147-154, 2000. (Pubitemid 30204975)
14. Evrard, A., Cuq, P., Robert, B., Vian, L., Pelegrin, A., and Cano, J. P. Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: in vitro and in vivo study. Int. J. Cancer, 80: 465-470, 1999. (Pubitemid 29019637)
15. Evrard, A., Cuq, P., Ciccolini, J., Vian, L., and Cano, J. P. Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase. Br. J. Cancer, 80: 1726-1733, 1999. (Pubitemid 29389624)
16. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H., and Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48: 589-601, 1988. (Pubitemid 18056527)
17. Ciccolini, J., Peillard, L., Evrard, A., Cuq, P., Aubert, C., Pelegrin, A., Cano, J. P., and Catalin, J. Enhanced antitumor activity of 5-FU in combination with 2′-deoxyinosine in human colorectal cell lines and human colon tumor xenografts. Clin. Cancer Res., 6: 1529-1535, 2000. (Pubitemid 30226243)
18. Yusuf, A., Vian, L., Sabatier, R., and Cano, J. P. In vitro detection of indirect-acting genotoxins in the comet assay using Hep G2 cells. Mutat. Res., 468: 234-277, 2000.
19. Rustum, Y. M. Clinical implications of 5-fluorouracil modulation. Oncology (Huntington), 7: 22-25, 1999.
20. Van Triest, B., Pinedo, H. M., Giaccone, G., and Peters, G. J. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors. Ann. Oncol., 14: 385-391, 2000. (Pubitemid 30333539)
21. Zhang, Z. G., Harstrick, A., and Rustum, Y. M. Mechanisms of resistance to fluoropyrimidines. Semin. Oncol., 19: 4-9, 1992.
22. Zhang, Z. G., Malmberg, M., Yin, M. B., Slocum, H. K., and Rustum, Y. M. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine. Biochem. Pharmacol., 45: 1157-1164, 1993. (Pubitemid 23079995)
23. Inaba, M., Naoe, Y., and Mitsuhashi, J. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells. Biol. Pharm. Bull., 21: 569-573, 1998. (Pubitemid 28317310)
24. Look, K. Y., Moore, D. H., Sutton, G. P., Prajda, N., Abongi, M., and Weber, G. Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinoma. Anticancer Res., 17: 2353-2356, 1997. (Pubitemid 27352619)
25. Chung, Y. M., Park, S., Park, J. K., Kim, Y., Kang, Y., and Yoo, Y. D. Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells. Cancer Lett., 159: 95-101, 2000.
26. Mader, R. M., Sieder, A. E., Braun, J., Rizovski, B., Kalipuiyan, M., Mueller, M. W., Jakesz, R., Rainer, H., and Steger, G. G. Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro. Biochem. Pharmacol., 54: 1233-1242, 1997. (Pubitemid 27497250)
27. Cuq, P., Evrard, A., Ciccolini, J., Vian, L., and Cano, J. P Fluoropyrimidine sensitivity of human MCF7 breast cancer cells stably transfected with human uridine phosphorylase. Br. J. Cancer, 84: 1677-1680, 2001. (Pubitemid 32612501)
28. Friedkin, M., and Roberts, D. The enzymatic synthesis of nucleosides. II. Thymidine and related pyrimidine nucleosides. J. Biol. Chem., 207: 257-266, 1957.
29. Peters, G. J., Laurensse, E., Leyva, A., and Pinedo, H. M. Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity. Eur. J. Cancer Clin. Oncol., 23: 1869-1881, 1987. (Pubitemid 18013328)
30. Inaba, M., Mitsuhashi, J., Sawada, H., Miike, N., Naoe, Y., Daimon, A., Koizumi, K., Tsujimoto, H., and Fukushima, M. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. Jpn. J. Cancer Res., 87: 212-220, 1996. (Pubitemid 26099498)
31. Barankiewicz, J., and Henderson, J. F. Ribose 1-phosphate metabolism in Erlich ascites tumor cells in vitro. Biochim. Biophys. Acta, 479: 371-377, 1977. (Pubitemid 8224010)
32. Tillman, D. M., Petak, I., and Houghton J. A. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Clin. Cancer Res., 5: 425-430, 1999. (Pubitemid 29085197)
33. Spiegelman, S., Sawyer, R., Nayak, R., Ritzi, E., Stolfi, R., and Martin, D. Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation. Proc. Natl. Acad. Sci. USA, 77: 4966-4970, 1980. (Pubitemid 11236547)
34. O'Dwyer, P. J., King, S. A., Hoth, D. F., and Leyland-Jones, B. Role of thymidine in biochemical modulation: a review. Cancer Res., 47: 3911-3919, 1987. (Pubitemid 17108445)
35. Gebbia, V., Testa, A., Borsellino, N., Cannata, G., Valenza, R., and Gebbia, N. Pharmacological modulation of 5-fluorouracil and its clinical implications: an overview. In Vivo, 7: 639-644, 1993. (Pubitemid 24095986)
36. Lonn, U., and Lonn, S. Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma. Cancer Res., 48: 4153-4157, 1988.
37. Szabados, E., Duggleby, R. G., and Christopherson, R. I. Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCR-FCEM leukemia cells. Int. J. Biochem. Cell. Biol., 28: 1405-1415, 1996. (Pubitemid 27037929)
38. Folkman, J. What is the role of thymidine phosphorylase in tumor angiogenesis. J. Natl. Cancer Inst. (Bethesda), 88: 1091-1092, 1996. (Pubitemid 26274601)
39. Takahashi, Y., Bucana, C. D., Akagi, Y., Liu, W., Cleary, K. R., Mai, M., and Ellis, L. M. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin. Cancer Res., 4: 429-434, 1998. (Pubitemid 28122759)
40. Salonga, D., Danenberg, K. D., Johnson, M., Metzger, R., and. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin. Cancer Res., 6: 1322-1327, 2000.
41. Van Triest, B., Pinedo, H. M., Blaawgeers, J. L., Van Diest, P. J., Schoenmakers, P. S., Voorn, D. A., Smid, K., Hoekman, K., Hoitsma, H. F., and Peters, G. J. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin. Cancer Res., 6: 1063-1072, 2000. (Pubitemid 30159368)
42. Yang, Q., Shan, L., Yoshimura, G., Taniguchi, E., Suzuma, T., Nakamura, Y., Nakamura, M., Utsunomiya, H., Tang, W., Sakurai, T., and Kakudo, K. Thymidine phosphorylase expression in invasive carcinoma: correlations with clinicopathologic variables and in vitro chemosensitivity to 5-FU. Anticancer Res., 19: 5543-5546, 1999. (Pubitemid 30093323)
43. Fox, S. B., Engels, K., Comley, M., Whitehouse, R. M., Turley, H., Gatter, K. C., and Harris, A. L. Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol., 8: 271-275, 1997. (Pubitemid 27153494)
44. Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., and Kaibara, N. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma. Br. J. Cancer, 81: 484-489, 1999. (Pubitemid 29458803)
45. Ackland, S. P., and Peters, G. J. Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs. Drug Resistance Updates, 2: 205-214, 1999. (Pubitemid 29526244)
46. Houghton, J. A., Harwood, F. G., and Tillman, D. M. Thymineless death in colon carcinoma cells is mediated via fas signaling. Proc. Natl. Acad. Sci. USA, 94: 8144-8149, 1997. (Pubitemid 27343791)